Latest updates for #Biotechentrepreneur

Fresh curated links around #biotechentrepreneur are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Argobio: the venture model building Europe’s next biotech champions
  • C-CAMP launches 9th edition of national bio entrepreneurship competition with Rs 20 cr at stake
  • Prime Venture, Leo Capital back biotech startup StrainX in $13M round

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

labiotech.eu /1 month ago

Argobio: the venture model building Europe’s next biotech champions

Our guest today is Thierry Laugel, Managing Partner of Kurma & Chairman of Argobio. Argobio has co-founded several companies from top European academic labs. The post Argobio:...

Read source
yourstory.com /3 weeks ago

C-CAMP launches 9th edition of national bio entrepreneurship competition with Rs 20 cr at stake

India’s largest biotech startup competition returns with Rs 20 crore prize pool, widening push to back science-led innovation beyond metro hubs.

Read source
yourstory.com /5 days ago

Prime Venture, Leo Capital back biotech startup StrainX in $13M round

Prime Venture Partners and Leo Capital lead investment as the IIT Delhi-founded startup bets on precision fermentation and bio-manufacturing for global markets.

Read source
biopharmadive.com /4 days ago

SR One’s Simeon George on how China is rewriting biotech’s venture playbook

The veteran investor says that the trove of ready-made prospects is making the global biotech ecosystem “more competitive” and steering dollars away from “half-baked ideas.”

Read source
fiercebiotech.com /1 month ago

Biotech Giants and Investors Gather to Solve the Commercialisation Puzzle This May in Hong Kong

Join global leaders at ASGH 2026 to bridge the gap between lab breakthroughs and market execution while unlocking growth in Asia’s health economy.

Read source
thestartupmag.com /1 month ago

4 Mistakes Biotech Startups Make — And How to Avoid Them

It’s no secret that finding success in the biotech industry can be extraordinarily challenging. With long timeframes (the discovery to The post 4 Mistakes Biotech Startups Make — A...

Read source
pharmexec.com /4 days ago

<![CDATA[Navigating Turbulent Markets: What Two Decades in Biotech Finance Taught Me About Building Companies That La...

Read source
fiercebiotech.com /1 month ago

AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs

Just a few years ago, Daniel Chen, M.D., Ph.D., was spending his days in his backyard, sketching out designs for new antibody-drug conjugates with a friend. Now, he’s sharing with...

Read source
pharmexec.com /1 month ago

<![CDATA[Lessons Learned in the Current Biotech Funding Environment]]>

Read source
medcitynews.com /1 week ago

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...

Read source
pharmexec.com /2 weeks ago

<![CDATA[From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box]]>

Read source
pharmexec.com /2 weeks ago

<![CDATA[The Relationship Between the Capital Markets and Biotech?]]>

Read source
fiercebiotech.com /1 month ago

Eying 3 approvals in 2 years, Ocugen’s CEO wants to bring gene therapy to the masses

Many gene therapy outfits focus on technical advances, Ocugen CEO Shankar Musunuri, Ph.D., said, meaning they miss out on broader commercial success.

Read source
labiotech.eu /1 month ago

The biggest biotech funding rounds in March 2026

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in March 2026. The post The biggest biotech funding round...

Read source
labiotech.eu /1 month ago

Mending university and venture capital relations: is it possible to see eye-to-eye? 

Discover how VCs and universities can work together to overcome the various challenges that affect current relations. The post Mending university and venture capital relations: is...

Read source
medcitynews.com /1 month ago

Executing Biologics Technology Transfer through Integrated Operating Models

As biologics modalities diversify and processes grow complex, the success of tech transfer depends on integrated execution rather than each procedural completion. The post Executin...

Read source
pharmexec.com /1 month ago

<![CDATA[Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology]]>

Read source
pharmexec.com /1 week ago

<![CDATA[Modern Communication Between FDA, Biotech, and Investors: Q&A with David Crean]]>

Read source
biopharmadive.com /1 month ago

Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more broadly appealing to...

Read source
fiercebiotech.com /4 weeks ago

The American Biotech Innovation Alliance launches to unify domestic strategy amid global competition

A cross-section of biotech leaders is launching the American Biotech Innovation Alliance (ABIA) with the goal of uniting stakeholders and defining a national strategy to sustain an...

Read source
yourstory.com /2 weeks ago

Meet LiteFold, a biotech startup using proprietary AI to speed up drug discovery

Bengaluru and Delaware-based LiteFold is a biotech AI-native platform designed to accelerate computational biology workflows.

Read source
labiotech.eu /1 month ago

Top biotech deals in March 2026 

Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high. The post Top biotech deals in March 2026  ap...

Read source
medcitynews.com /2 weeks ago

This TechBio Startup Just Raised $2B Without Disclosing a Single Detail About Its Drugs

Isomorphic Labs’ Series B financing is the second largest ever raised by a biotech startup. Like the largest one, Isomorphic is also opaque about its drug programs. The post This...

Read source
cafepharma.com /2 weeks ago

BridgeBio

BridgeBio Anonymous (not verified) Mon, 05/11/2026 - 11:23 field_thread_url https://cafepharma.com/boards/threads/bridgebio.698762/ boar...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering #Biotechentrepreneur

cafepharma.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

thestartupmag.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source